Skip to content
Review

Stroke Heart Syndrome: Neuroimmune and Metabolic Crosstalk with Conceptual Approaches for Precision Therapeutics.

Aug 2026 · Cardiovascular Drugs and Therapy · 1 citation · 44 references
Medicine

TL;DR

This review proposes a hypothesis-generating conceptual framework that categorizes SHS into three endophenotypes, including neurogenic arrhythmic (Type I), inflammatory thrombotic (Type II), and metabolic remodeling (Type III), and potential phenotype-specific interventions include beta blockers for neural stabilization, NETs degradation for immunomodulation, and metabolic pathway antagonists.

View source

Similar papers

Review Open access Aug 2026

Targeting Inflammation in Chronic Kidney Disease: Pathophysiological Insights and Emerging Therapeutic Strategies

Renin–angiotensin system inhibitors, sodium–glucose cotransporter-2 inhibitors, finerenone, and glucagon-like peptide-1 receptor agonists improve cardiorenal outcomes and have plausible anti-inflammatory actions, although inflammatory mediation remains unproven.

Aris Tsalouchos, P. Dattolo · 0 citations
Review Open access Aug 2026

TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity.

BACKGROUND Cardiovascular diseases remain the leading cause of global morbidity and mortality, with pathogenesis extending beyond hemodynamic derangements to involve chronic, maladaptive immune-metabolic crosstalk. Macrophage functional identity has evolved beyond the M1/M2 paradigm toward a model of high heterogeneity...

Ke Yang, Xuefang Ma, Binyan Wang et al. · 0 citations
Review Jul 2026

Chronic kidney disease‑associated encephalopathy: Clinical features, pathomechanisms and emerging therapeutic strategies (Review).

The present review systematically outlines the clinical manifestations, core pathogenic mechanisms and emerging therapeutic strategies for CKD‑associated encephalopathy, and the targeted interventions on the gut‑kidney‑brain axis.

Nanling Zeng, Ling Jiang, Yang Zhang et al. · 0 citations
Review Open access Jul 2026

Central neuroendocrine dysregulation in ischaemic stroke sequelae: pathophysiological mechanisms—a narrative review

Ischemic stroke (IS) prognosis is frequently compromised by secondary systemic and neuropsychiatric complications extending beyond the initial brain injury. The hypothalamic–pituitary–adrenal (HPA) axis, the primary neuroendocrine regulator, plays a pivotal yet underappreciated role in the pathogenesis of these sequela...

Han Gong, Dan Liu, Xiang-Zheng Wang et al. · 0 citations
Review Open access Jul 2026

Gut microbiota-mediated neuroinflammation following stroke: mechanisms and intervention strategies

Stroke is a complex and highly heterogeneous acute cerebrovascular disease characterized by high incidence, disability rates, and mortality. The occurrence of a stroke is the result of a series of chain reactions. Neuroinflammation, as a core component of the pathological process of stroke, serves as the dynamic hub of...

Lili Teng, Minmin Wu, Wenjing Song et al. · 0 citations
Review Open access Jul 2026

Brain heart crosstalk after ischemic stroke toward a unified framework for pathophysiology and precision medicine

Background Acute ischemic stroke and cardiac dysfunction engage in a complex bidirectional interplay that critically determines patient outcomes. Despite growing recognition of the brain-heart axis, a comprehensive mechanistic framework integrating traditional and emerging pathways remains lacking. Moreover, existing r...

Pengpeng Li, Yangyang Gao, Wei Liu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.